MedPath

Safety of Tranexamic Acid in Reducing Blood Loss Myomectomy.

Not Applicable
Conditions
Myoma
Interventions
Drug: women receiving tranexamic acid
Registration Number
NCT04694677
Lead Sponsor
Aljazeera Hospital
Brief Summary

Uterine leiomyomas (fibroids) are the most common benign tumors among women . Fibroids are found in approximately 15% to 30% of women in the reproductive age group

Detailed Description

Although most of them are asymptomatic, 20-50% of fibroids may cause problems such as heavy menstrual bleeding, anemia, pelvic pain, pressure symptoms from extrinsic compression of the colorectal and urinary tract, infertility, and recurrent pregnancy losses, where surgical intervention is often indicated

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • women with myomas
Exclusion Criteria
  • with with malignant lesions

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
women receiving misoprostolwomen receiving misoprostol-
women receiving tranexamic acidwomen receiving tranexamic acid-
Primary Outcome Measures
NameTimeMethod
the number of women who will have less blood loss48 hours

how many women will have less blood loss

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Algazeerah

🇪🇬

Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath